A New Jersey federal trial judge has dumped a motion to dismiss a putative class action against the makers and distributors of MonaVie, a “super juice” allegedly hawked in a nationwide pyramid scheme as a treatment for cancer, arthritis, stroke, diabetes and allergies, among other conditions.
On August 19, U.S. District Judge William Martini allowed Pontrelli v. MonaVie to proceed, finding New Jersey plaintiff Lisa Pontrelli’s complaint meets the legal requirements to pursue claims of fraud and unjust enrichment against Utah-based MonaVie, Inc. Read the judge’s ruling here.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]